Peters, M. http://orcid.org/0000-0002-4268-0548
de Jong, J.
Scharmga, A.
van Tubergen, A.
Geusens, P.
Loeffen, D.
Weijers, R.
Boyd, S. K.
Barnabe, C.
Stok, K. S.
van Rietbergen, B.
van den Bergh, J.
Funding for this research was provided by:
Pfizer (WS2056904)
Weijerhorst foundation (WH-2)
Article History
Received: 21 June 2017
Accepted: 30 April 2018
First Online: 15 May 2018
Ethics approval and consent to participate
: Ethical approval was obtained from the Conjoint Health Research Ethics Board at the University of Calgary, Canada (REB 15–0582). All participants signed informed consent.
: PG: grants received from AMGEN, ABBVIE, MSD, WILL, ROCHE, BMS and UCB. CB: grants received from AMGEN, ROCHE, ABBVIE, BMS, Pfizer, Eli Lilly. BvR: consultant for Scanco Medical AG. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.